TNL Mediagene (TNMG)
NASDAQ: TNMG · Real-Time Price · USD
0.3850
+0.0730 (23.40%)
May 13, 2025, 1:07 PM - Market open

TNL Mediagene Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Revenue
48.4935.8420.01
Revenue Growth (YoY)
35.31%79.10%-
Cost of Revenue
30.7623.1912.27
Gross Profit
17.7412.657.74
Selling, General & Admin
6216.428.65
Research & Development
3.053.332.51
Operating Expenses
65.0619.7511.16
Operating Income
-47.32-7.1-3.42
Interest Expense
-0.39-0.29-0.14
Interest & Investment Income
0.020.020.01
Currency Exchange Gain (Loss)
-0.16-0.01-0.12
Other Non Operating Income (Expenses)
-8.415.87-7.98
EBT Excluding Unusual Items
-56.26-1.51-11.64
Gain (Loss) on Sale of Assets
000
Asset Writedown
-29.03-0.3-
Pretax Income
-85.28-1.81-11.64
Income Tax Expense
-0.31-0.59-0.25
Earnings From Continuing Operations
-84.98-1.22-11.39
Minority Interest in Earnings
-0.030.410.38
Net Income
-85-0.8-11.01
Net Income to Common
-85-0.8-11.01
Shares Outstanding (Basic)
25189
Shares Outstanding (Diluted)
25189
Shares Change (YoY)
33.29%99.87%-
EPS (Basic)
-3.46-0.04-1.20
EPS (Diluted)
-3.46-0.04-1.20
Free Cash Flow
-10.3-1.51-0.81
Free Cash Flow Per Share
-0.42-0.08-0.09
Gross Margin
36.58%35.30%38.69%
Operating Margin
-97.58%-19.80%-17.08%
Profit Margin
-175.29%-2.25%-55.04%
Free Cash Flow Margin
-21.24%-4.22%-4.06%
EBITDA
-45.31-5.37-2.4
EBITDA Margin
-93.44%-14.99%-12.00%
D&A For EBITDA
21.731.02
EBIT
-47.32-7.1-3.42
EBIT Margin
-97.58%-19.80%-17.08%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q